Cellular Biomedicine Group, of Shanghai,appointed Terry A. Belmont chairman of the board, and Tony (Bizuo) Liu CEO, effective Feb. 7. Belmont has been an independent director since December 2013 and vice chairman of the board since March 2015. He retired in June 2015 as CEO at University of California, Irvine Health.